Seattle Genetics is an eminent firm that concentrates on biotechnology matters. True to its name, it’s headquartered in Bothell, Washington in the Seattle region. The objective at Seattle Genetics is to create modern and creative cancer treatment options. Seattle Genetics specializes in monoclonal treatments that are centered around antibodies (proteins that can pinpoint pathogens). Seattle Genetics was established in 1998. Its founder is named Clay Siegall, Ph.D. He’s Seattle Genetics’ Chief Executive Officer and President. He’s also a board chairman for the firm.
There are quite a few other management executives who work for Seattle Genetics. These varied professionals include Chief Operating Officer Eric L. Dobmeier, General Counsel Jean I. Liu, J.D., Technical Operations and Process Sciences Executive Vice President Vaughn B. Himes, Ph.D. and Chief Medical Officer Jonathan Drachman, M.D.
Siegall is a seasoned scientist. He has extensive training in his vocation. Targeted cancer treatments are a specific area of concentration for Siegall. When he established Seattle Genetics, his aim was to zero in in comprehensive research, scientific discoveries and modern drug development techniques. Siegall also established the company out of a desire to assist people. Siegall worked hard to get Seattle Genetics the success it now enjoys. He made ADCs (antibody-drug conjugates). He got FDA (United States Food and Drug Administration) approval for ADCETRIS in 2011.
This prominent figure in the scientific realm had a rewarding career prior to helping create Seattle Genetics. He had a position at the Bristol-Myers Squibb Pharmaceutical Research Institute between the years of 1991 and 1997. Before that, he had a job at National Cancer Institute, National Institutes of Health. He started working at the National Cancer Institute in 1988. He left it three years later. Siegall is a Board of Directors member for numerous entities. These include Alder BioPharmaceuticals, Washington Roundtable, Mirna Therapeutics and Ultragenyx Pharmaceutical. Siegall has been acknowledged with various coveted awards, too. He was named Entrepreneur of the Year in 2012 by Ernst & Young’s Pacific Northwest division.
Siegall graduated from the University of Maryland with a zoology bachelor of science degree. He graduated from George Washington University with a genetics Ph.D. as well.